Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study
Lambert Assoumou, Raghiatou Baldé, Christine Katlama, Baptiste Abbar, Pierre Delobel, Thierry Allegre, Armelle Lavole, Alain Makinson, Olivia Zaegel-Faucher, Laurent Greillier, Cathia Soulie, Marianne Veyri, Mathilde Bertheau, Michèle Algarte Genin, Séverine Gibowski, Anne-Geneviève Marcelin, Kevin Bihan, Marine Baron, Dominique Costagliola, Olivier Lambotte, Jean-Philippe Spano
Journal for ImmunoTherapy of Cancer Aug 2024, 12 (8) e009728; DOI: 10.1136/jitc-2024-009728